Uncategorized
Showing 81–86 of 86 results
Filters Sort results
Reset Apply
Cell Line | Cell Line Alias | Cell Type | Disease | Genetic Alteration/Mutation | Sex | Age at Collection | Ethnicity | Genetically Related Cell Lines | dbGaP Data |
|---|---|---|---|---|---|---|---|---|---|
Human iPS | PACS2 syndrome | Whole exome sequencing revealed a de novo autosomal dominant heterozygous pathogenic variant in the PACS2 gene: p.Glu209Lys/p.E209K (c.625G>A) | Female | 10 Months | Caucasian | No | No | ||
I3 | Human ES | None reported | Female | No | No | ||||
I4 | Human ES | None reported | Female | No | No | ||||
I6 | Human ES | None reported | Male | No | No | ||||
HSF-6 | Human ES | None reported | Female | No | No | ||||
pZD14-iPSC1C129, WAi001-B-1, WISCi017-A-1 | Modified Human iPS | None reported | Male | No | No | ||||
FX-iPSC-Nluc1 | Modified Human iPS | Fragile X syndrome | Male | 8 Years | No | No | |||
Human iPS | None reported | Female | Neonatal | Caucasian | No | No | |||
Human iPS | None reported | Female | Neonatal | Caucasian | No | No | |||
Human iPS | None reported | Female | Neonatal | Caucasian | No | No |